Explore

Rapid Read Rapid Read
FDA Classifies Cough Drops Recall as Moderate Risk Due to Quality Concerns

FDA Classifies Cough Drops Recall as Moderate Risk Due to Quality Concerns

The U.S. Food and Drug Administration (FDA) has classified a nationwide recall of multiple cough drop products as a Class II recall, indicating a moderate risk to consumers. The recall, initiated on March 20, 2026, was prompted by an FDA inspection at an overseas manufacturing facility that revealed conditions potentially affecting product quality. The affected products, manufactured in China by Xiamen Kang Zhongyuan Biotechnology Co., Ltd., include various flavors and are distributed under several brand names such as Exchange Select and Caring Mill. These products are sold in packages ranging from 25 to 90 counts and have expiration dates in 2026. The FDA's classification suggests that while the likelihood of serious harm is low, the use of these products may cause temporary or medically reversible adverse health effects.
AP News AP News
FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures

FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures

Federal health officials will meet this summer to consider easing restrictions on a controversial group of drugs popular with followers of Robert F. Kennedy Jr.'s Make America Healthy Again movement
Trendline Trendline
FDA Considers Easing Restrictions on Unproven Peptides Popular Among Wellness Influencers

FDA Considers Easing Restrictions on Unproven Peptides Popular Among Wellness Influencers

FDA Considers Easing Restrictions on Unproven Peptides Popular Among Wellness Influencers
Reuters Reuters
Exclusive-China weighs curbs on exports of solar manufacturing equipment to US

Exclusive-China weighs curbs on exports of solar manufacturing equipment to US

BEIJING/LOS ANGELES, April 15 (Reuters) - Chinese officials have held initial talks with providers of equipment to make solar panels as they consider limiting exports of the most advanced technology to the United States, said five people with knowledge of the consultations.
Rapid Read Rapid Read
FDA Considers Easing Restrictions on Unproven Peptides Amid RFK Jr.'s Advocacy

FDA Considers Easing Restrictions on Unproven Peptides Amid RFK Jr.'s Advocacy

The U.S. Food and Drug Administration (FDA) is set to hold a meeting this summer to discuss the potential easing of restrictions on several peptide injections. These peptides, which are unapproved therapies, have gained popularity among wellness influencers and celebrities for their purported benefits in muscle building, injury healing, and anti-aging. Health Secretary Robert F. Kennedy Jr. has been a vocal advocate for loosening these regulations, despite the lack of substantial research supporting the safety and efficacy of these peptides. The FDA plans to consult a panel of outside advisers to review seven specific peptides, including BPC-157, which is marketed for injury healing and inflammation reduction. The agency has indicated it will remove these peptides from a list of high-risk, unapproved drugs, potentially allowing them to be produced by pharmacies.
Rapid Read Rapid Read
CPSC Issues Recalls on Products Due to Burn, Injury, and Death Risks

CPSC Issues Recalls on Products Due to Burn, Injury, and Death Risks

The U.S. Consumer Product Safety Commission (CPSC) has announced recalls for a range of consumer products due to safety concerns that could lead to serious burns, injuries, or death. The recalled items include dietary supplements, household electronics, pool equipment, children's clothing, and more, many of which were sold through major online platforms like Amazon. Specific recalls include Vitaquest International's iron supplements due to non-compliant packaging, and various lighting products with battery safety issues. Bissell's steam cleaners and Wybotics' pool vacuums are also recalled due to potential burn hazards.
Rapid Read Rapid Read
CPSC Issues Recalls on Various Consumer Products Due to Safety Risks

CPSC Issues Recalls on Various Consumer Products Due to Safety Risks

The U.S. Consumer Product Safety Commission (CPSC) has announced recalls on a range of consumer products due to potential safety hazards, including risks of burns, injuries, and death. The recalls affect dietary supplements, household electronics, pool equipment, children's clothing, and more, many of which were sold through major online platforms like Amazon. Notable recalls include Vitaquest International's iron supplements for failing child-resistant packaging standards, and Bissell's steam cleaners due to defects causing hot water ejection. The CPSC advises consumers to stop using these products immediately and seek refunds or replacements.
Rapid Read Rapid Read
FDA Expands Recall of Dietary Supplement Due to Allergen Risks

FDA Expands Recall of Dietary Supplement Due to Allergen Risks

Blueroot Health has expanded a voluntary recall of its Vital Nutrients Aller-C dietary supplements due to the potential presence of undeclared allergens, including egg, hazelnut, and soy. The recall, initially announced in late March, now includes all products manufactured using lot 25E04. The affected supplements, sold in bottles of 100 or 200 capsules, were distributed nationwide through various online retailers. The undeclared allergens were discovered during routine internal testing, prompting the company to notify the FDA and expand the recall. No illnesses have been reported so far, but the FDA warns that consumption of these supplements could lead to serious allergic reactions in sensitive individuals.
Rapid Read Rapid Read
Blueroot Health Expands Recall of Dietary Supplements Due to Life-Threatening Allergens

Blueroot Health Expands Recall of Dietary Supplements Due to Life-Threatening Allergens

Blueroot Health has expanded its voluntary recall of Vital Nutrients Aller-C dietary supplements after discovering undeclared allergens that pose serious health risks. The recall, initially announced in late March, now includes all products manufactured using lot 25E04. The undeclared allergens include egg, hazelnut, and soy, which could cause life-threatening reactions in sensitive individuals. The affected supplements, sold in bottles of 100 or 200 capsules, were distributed nationwide through the company's website and other online retailers. The issue was identified during routine internal testing, prompting Blueroot Health to notify the FDA and expand the recall. No illnesses have been reported so far, but consumers with allergies to the undeclared ingredients are advised to stop using the product immediately and return it for a replacement.
Rapid Read Rapid Read
Blueroot Health Expands Recall of Dietary Supplements Due to Undeclared Allergens

Blueroot Health Expands Recall of Dietary Supplements Due to Undeclared Allergens

Blueroot Health has expanded a voluntary recall of its Vital Nutrients Aller-C dietary supplements after discovering undeclared food allergens that could pose serious health risks. The recall, initially announced in late March, now includes all products manufactured using lot 25E04 due to the possible presence of egg, hazelnut, and soy, which were not declared on the product label. The affected supplements were distributed nationwide through the company's website and other online retailers. The presence of undeclared allergens was discovered during routine internal testing, prompting Blueroot Health to notify the FDA and voluntarily expand the recall.
Rapid Read Rapid Read
Lundberg Family Farms Recalls White Rice Over Contamination Concerns

Lundberg Family Farms Recalls White Rice Over Contamination Concerns

Lundberg Family Farms has issued a recall for its Organic Jasmine White Rice due to potential contamination with foreign material. The recall affects two-pound bags sold at major retailers, including Wegmans, Walmart, Target, and Whole Foods. The recall, which began on April 4, is classified as a Class II recall, indicating that the affected products may cause temporary or medically reversible adverse health consequences. The recall is limited to one production run, and no illnesses have been reported. The affected bags have specific lot codes and best-by dates, and the issue has been reported to federal authorities.
Trendline Trendline
Telix Pharmaceuticals Advances in Radiopharmaceuticals with FDA Nod for Brain Cancer Imaging Agent

Telix Pharmaceuticals Advances in Radiopharmaceuticals with FDA Nod for Brain Cancer Imaging Agent

Telix Pharmaceuticals Advances in Radiopharmaceuticals with FDA Nod for Brain Cancer Imaging Agent